MARKET

RNAZ

RNAZ

Transcode Therapeutics Inc
NASDAQ
0.4950
+0.0050
+1.02%
After Hours: 0.4901 -0.0049 -0.99% 19:58 03/31 EDT
OPEN
0.4535
PREV CLOSE
0.4900
HIGH
0.5699
LOW
0.4263
VOLUME
4.61M
TURNOVER
--
52 WEEK HIGH
66.33
52 WEEK LOW
0.4263
MARKET CAP
11.55M
P/E (TTM)
-0.0018
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RNAZ last week (0324-0328)?
Weekly Report · 14h ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 3d ago
Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Benzinga · 3d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 4d ago
TransCode Therapeutics Reports Initial Dosing In Fourth Cohort Of Phase 1 Clinical Trial With TTX-MC138
Benzinga · 4d ago
Transcode Therapeutics begins dosing in fourth cohort of Phase 1 cancer trial
TipRanks · 4d ago
TRANSCODE THERAPEUTICS, INC. ANNOUNCES CLOSING OF REGISTERED DIRECT OFFERING
Reuters · 6d ago
Biotech Alert: Searches spiking for these stocks today
TipRanks · 6d ago
More
About RNAZ
More
TransCode Therapeutics, Inc. is a clinical-stage oncology company focused on treating metastatic disease. The Company is focused on treating cancer through the design and delivery of ribonucleic acid (RNA) therapeutics based on its TTX nanoparticle platform. The Company’s lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. Its preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1 (PD-L1), and two indication agnostic programs, TTX-RIGA, an RNA-based agonist of the retinoic acid- inducible gene I (RIG-I), targeting activation of innate immunity in the tumor microenvironment; and TTX- CRISPR, a CRISPR/Cas9-based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells. The Company’s pipeline also includes TTX-mRNA, a tumor-type specific mRNA-based platform for the development of cancer vaccines.
Recently
Symbol
Price
%Change

Webull offers Transcode Therapeutics Inc stock information, including NASDAQ: RNAZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RNAZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RNAZ stock methods without spending real money on the virtual paper trading platform.